This website uses cookies to enhance the user experience.
GJ

Geir Johansen1963

Shareholdings
9
6
Norway Business roles
14

Roles

Management

NameRoleTotal operating incomeTotal equityShares
B
BIAC AS
Managing Director/CEO
-
-59,075
100 %
directly
B
BIOMEDIC AS
Managing Director/CEO
-
-276,597
50 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
B
BIAC AS
Chairman
-
-59,075
100 %
directly
S
SKIN MEDICAL GRUPPEN AS
Contact Person
1,156,294
-187,914
100 %
indirectly
E
ECOON HOLDING AS
Contact Person
-
-71,724
100 %
directly
C
COSMO SANDVIKA AS
Board Member
414,005
-319,083
50 %
indirectly
B
BIOMEDIC AS
Board Member
-
-276,597
50 %
indirectly
S
SANDVIKA HUDKLINIKK AS
Board Member
2,144,679
-999,986
20 %
indirectly
N
Contact Person
-
-
-
B
BLUEBIRDS
Chairman
-
-
-
F
FRYD KRAGERØ AS
Deputy Chair
353,559
35,894
-
Last update: Nov 22, 2023

Related industries3

  • Wholesale and retail trade; repair of motor vehicles and motorcycles
  • Other service activities
  • Human health and social work activities

Shares owned by Geir Johansen

NameShare classTotal operating incomeTotal equityShare
B
BIAC AS
Ordinære aksjer
0
-59,075
100 %
directly
E
ECOON HOLDING AS
Ordinære aksjer
0
-71,724
100 %
directly
S
SKIN MEDICAL GRUPPEN AS
1,156,294
-187,914
100 %
indirectly
C
COSMO SANDVIKA AS
414,005
-319,083
50 %
indirectly
B
BIOMEDIC AS
0
-276,597
50 %
indirectly
S
SAKTE FART KRAGERØ AS
1,476,137
-171,574
33.33 %
indirectly
S
SANDVIKA HUDKLINIKK AS
2,144,679
-999,986
20 %
indirectly
G
GK MARITIM REP AS
Ordinære aksjer
2,153,097
-88,203
10 %
directly
G
GK OPPLAG AS
249,325
71,778
10 %
indirectly
A
AKER CARBON CAPTURE ASA
NO0010890304
203,000
1,817,549,000
< 0.01 %
directly
F
FLYR AS
NO0010931900
125,939,000
163,919,000
< 0.01 %
directly
I
IDEX BIOMETRICS ASA
NO0003070609
4,138,000
15,922,000
< 0.01 %
directly
P
PCI BIOTECH HOLDING ASA
NO0010405640
0
78,423,000
< 0.01 %
directly
B
BERGENBIO ASA
NO0010650013
980,000
89,213,000
< 0.01 %
directly
S
SAGA PURE ASA
NO0010572589
8,421,000
865,668,000
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024